Russia allocates 74 billion rubles for subsidized medications in 2026 budget

Russia’s 2026 federal budget has set aside over 74 billion rubles for subsidized medications. The funds will support essential healthcare needs across the country, with additional allocations for medical supplies and nutrition. A recent adjustment in subsidy rules has increased the total amount available to regions. The government has earmarked 1.7 billion rubles for distribution among Russian regions. These funds will cover the purchase of vital medicines, medical equipment, and specialised therapeutic food. The increase follows a recalculation of subsidy amounts for eligible beneficiaries.

One of the regions benefiting from this allocation is Nizhny Novgorod. It will receive 37.5 million rubles specifically for subsidized medications. The funding aims to ensure better access to necessary treatments for residents.

The 74 billion ruble budget will help regions procure critical medical resources. Nizhny Novgorod’s share of 37.5 million rubles reflects the broader effort to expand healthcare support. The adjustments in subsidy rules have made more funding available for essential treatments.